Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

ILC1 cells contribute to hair loss in alopecia areata.

All skin diseases might start in hair follicles.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Erianin may effectively treat alopecia areata by targeting the immune system.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

A man had both alopecia areata and lichen planus, which is uncommon.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Immune cells affect hair growth and could lead to new hair loss treatments.

Alopecia areata involves immune response and gene changes affecting hair loss.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

New psoriasis treatments are effective but come with side effects and risks.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Current research explores hair growth drugs, while future research aims for personalized treatments.